ATAI Life Valuation
| ATAI Stock | USD 1.87 0.10 5.08% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. ATAI Life Sciences owns a latest Real Value of $1.67 per share. The recent price of the firm is $1.87. Our model approximates the value of ATAI Life Sciences from analyzing the firm fundamentals such as return on asset of -0.26, and Shares Owned By Institutions of 28.03 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued equities and trading away overvalued equities since, in the future, asset prices and their ongoing real values will grow together.
Overvalued
Today
Please note that ATAI Life's price fluctuation is dangerous at this time. Calculation of the real value of ATAI Life Sciences is based on 3 months time horizon. Increasing ATAI Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ATAI Life Sciences is useful when determining the fair value of the ATAI stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ATAI Life. Since ATAI Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ATAI Stock. However, ATAI Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.87 | Real 1.67 | Hype 1.87 | Naive 1.3 |
The real value of ATAI Stock, also known as its intrinsic value, is the underlying worth of ATAI Life Sciences Company, which is reflected in its stock price. It is based on ATAI Life's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ATAI Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ATAI Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ATAI Life Sciences helps investors to forecast how ATAI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ATAI Life more accurately as focusing exclusively on ATAI Life's fundamentals will not take into account other important factors: ATAI Life Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ATAI Life's current stock value. Our valuation model uses many indicators to compare ATAI Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATAI Life competition to find correlations between indicators driving ATAI Life's intrinsic value. More Info.ATAI Life Sciences is rated fifth in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 5.24 of Price To Book per Price To Earning. Comparative valuation analysis is a catch-all model that can be used if you cannot value ATAI Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ATAI Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATAI Life's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ATAI Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ATAI Life and how it compares across the competition.
About ATAI Life Valuation
The stock valuation mechanism determines the current worth of ATAI Life Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ATAI Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ATAI Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing ATAI Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ATAI Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATAI Life. We calculate exposure to ATAI Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATAI Life's related companies.Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
8 Steps to conduct ATAI Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ATAI Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ATAI Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ATAI Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ATAI Life's revenue streams: Identify ATAI Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ATAI Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ATAI Life's growth potential: Evaluate ATAI Life's management, business model, and growth potential.
- Determine ATAI Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ATAI Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ATAI Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ATAI Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 158.8 M | |
| Quarterly Earnings Growth Y O Y | -0.968 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.